IP Library Assignment 068031/0202
Patent Assignment
Reel/Frame 068031/0202

Security Interest

Recorded: 2024-07-19 Pages: 9
Assignor
ENDO OPERATIONS LIMITED
Executed: 2024-04-23
Assignee
COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
1505 ENERGY PARK DRIVE, ATTENTION: CORPORATE TRUST SERVICES – ENDO FINANCE HOLDINGS, INC. ADMINISTRATOR, ST. PAUL, MINNESOTA, 55108
Covered Properties (29)
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Patent: 7,262,253 →
Application: 10/727,083 →
Publication: US 2005/0119404
Controlled-release compositions
Patent: 8,487,002 →
Application: 11/111,996 →
Publication: US 2006/0240107
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Patent: 7,988,998 →
Application: 11/112,008 →
Publication: US 2007/0003618
Ultrapure 4-Methylpyrazole
Patent: 7,553,863 →
Application: 11/279,708 →
Publication: US 2007/0244330
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Patent: 8,895,066 →
Application: 12/252,117 →
Publication: US 2009/0130183
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,448 →
Application: 12/336,495 →
Publication: US 2009/0175937
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,449 →
Application: 12/639,664 →
Publication: US 2010/0239662
Misuse Preventative, Controlled Release Formulation
Patent: 8,691,270 →
Application: 13/919,476 →
Publication: US 2013/0344142
Misuse Preventative, Controlled Release Formulation
Patent: 8,685,447 →
Application: 13/919,499 →
Publication: US 2014/0004191
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,833 →
Application: 14/195,813 →
Publication: US 2014/0193494
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,013 →
Application: 14/195,833 →
Publication: US 2014/0248346
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,834 →
Application: 14/305,895 →
Publication: US 2014/0294954
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,014 →
Application: 14/305,935 →
Publication: US 2014/0294955
Solid Formulations of Liquid Biologically Active Agents
Application: 15/817,907 →
Publication: US 2018/0140706
Method of Assessing and Treating Cellulite
Application: 15/909,991 →
Publication: US 2018/0250217
Method of Producing Collagenase
Application: 15/939,231 →
Publication: US 2018/0327731
Phenylephrine Hydrochloride Compositions and Containers
Application: 17/154,516 →
Publication: US 2021/0228507
N-Acetylcysteine Compositions and Methods
Application: 17/177,797 →
Publication: US 2021/0251889
Isoproterenol Compositions and Methods
Application: 17/179,078 →
Publication: US 2021/0259994
Method of Assessing and Treating Cellulite
Application: 17/461,481 →
Publication: US 2021/0386644
Method of Purifying and Isolating Collagenase
Application: 17/559,782 →
Publication: US 2022/0119791
N-Acetylcysteine Compositions and Methods
Application: 17/857,587 →
Publication: US 2022/0331239
Hydralazine Compositions and Methods
Application: 18/146,756 →
Publication: US 2023/0201197
Method of Producing Collagenase
Application: 18/169,480 →
Publication: US 2024/0110171
Sodium Bicarbonate Injectable Formulation and Methods Thereof
Application: 18/278,153 →
Publication: US 2024/0131056
N-Acetylcysteine Compositions and Methods
Application: 18/359,685 →
Publication: US 2023/0364008
Isoproterenol Compositions and Methods
Application: 18/475,954 →
Publication: US 2024/0024260
Method of Assessing and Treating Cellulite
Application: 18/482,998 →
Publication: US 2024/0041744
Oxytocin Compositions and Methods
Application: 63/616,999 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 26, 2018
From: SHEAFFER, CHRISTINE A.; BERBAUM, MICHAEL; HANNA, JOHN; DZIADOSZ, JASON
To: ENDO VENTURES LIMITED
Reel/Frame 046633/0862 →
Assignment of Assignor's Interest Aug 28, 2019
From: DAVIDSON, JEFFREY; MCLANE, MICHAEL; LIU, GENZHOU
To: ENDO VENTURES LIMITED
Reel/Frame 050199/0939 →
Merger Apr 8, 2020
From: PALADIN LABS (BARBADOS) INC. (COMPANY #30304); LABOPHARM (BARBADOS) LIMITED (COMPANY # 21899)
To: LABOPHARM (BARBADOS) LIMITED (COMPANY # 36646)
Reel/Frame 052350/0943 →
Change of Address Apr 8, 2020
From: LABOPHARM (BARBADOS) LIMITED
To: LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052351/0048 →
Assignment of Assignor's Interest Apr 8, 2020
From: LUO, LAIBIN; RAVENELLE, FRANCOIS; GORI, SANDRA; LESSARD, DAVID
To: LABOPHARM INC.; LABOPHARM EUROPE LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052348/0073 →
Assignment of Assignor's Interest Apr 8, 2020
From: RAVENELLE, FRANCOIS; GORI, SANDRA; LESSARD, DAVID; LUO, LAIBIN
To: LABOPHARM INC.; LABOPHARM EUROPE LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052348/0118 →
Assignment of Assignor's Interest Apr 8, 2020
From: LABOPHARM INC.
To: CHIMIGEN INC.
Reel/Frame 052348/0172 →
Change of Name Apr 8, 2020
From: CHIMIGEN INC.
To: LABOPHARM INC.
Reel/Frame 052348/0178 →
Change of Name Apr 8, 2020
From: LABOPHARM (BARBADOS) LIMITED
To: PALADIN LABS (BARBADOS) INC.
Reel/Frame 052348/0218 →
Merger Apr 8, 2020
From: LABOPHARM INC.
To: PALADIN LABS INC.
Reel/Frame 052348/0223 →
Change of Name Apr 8, 2020
From: LABOPHARM EUROPE LIMITED
To: PALADIN LABS EUROPE LIMITED
Reel/Frame 052348/0240 →
Confirmatory Grant of Security Interest in United States Patents May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
Assignment of Assignor's Interest Jan 21, 2021
From: SOPPIMATH, KUMARESH; HINGORANI, TUSHAR; JAIN, HARSHIL H.; PURI, REEMA AJITKUMAR
To: NEVAKAR INC.
Reel/Frame 054986/0977 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0162 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0170 →
Assignment of Assignor's Interest May 6, 2021
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES LIMITED
Reel/Frame 056168/0284 →
Assignment of Assignor's Interest Aug 13, 2021
From: NEVAKAR INC.
To: NEVAKAR INJECTABLES INC.
Reel/Frame 057183/0825 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
Assignment of Assignor's Interest May 9, 2022
From: NEVAKAR INJECTABLES INC.
To: ENDO VENTURES LIMITED
Reel/Frame 059867/0929 →
Change of Name Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
Assignment of Assignor's Interest Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
Change of Name Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
Assignment of Assignor's Interest Apr 23, 2024
From: PALADIN LABS INC.
To: PALADIN PHARMA INC.
Reel/Frame 067203/0281 →
Release of Security Interest Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0376 →
Release of Security Interest Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0390 →